Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...

Real-world Roswell Park analysis links T-DXd to improved long-term overall survival versus standard chemotherapy in ...

My cousin, who's in her 30s, was recently diagnosed with colorectal cancer. I've always thought of colorectal cancer as ...

Enrollment concludes with just over 60 patients participating across seven clinical sites located throughout the United StatesVANCOUVER, ...

PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor ...

The study evaluated Leronlimab, an investigational antibody, in combination with standard therapies TAS-102 and Bevacizumab, a targeted therapy that blocks tumor growth. ・The study showed positive ...

Colorectal cancer remains a major health concern. Experts predict there will be 84,160 new cases in men and 74,690 in women in the United States by the end of 2026. It is now the third most common ...

CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced the expansion of its research program to ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

According to the American Cancer Society, colorectal cancer is the second leading cause of cancer death. Enrichment of regulatory T cells (T-regs) in solid cancers is generally associated with poor ...

Colorectal cancer rates are rising, and mortality rates for this disease are relatively high; in 2022 alone about 1.9 million ...